Fracture behavior of a composite of bone and calcium sulfate/hydroxyapatite.


Journal

Journal of the mechanical behavior of biomedical materials
ISSN: 1878-0180
Titre abrégé: J Mech Behav Biomed Mater
Pays: Netherlands
ID NLM: 101322406

Informations de publication

Date de publication:
06 2022
Historique:
received: 09 06 2021
revised: 19 03 2022
accepted: 25 03 2022
pubmed: 7 4 2022
medline: 22 4 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

Calcium sulfate/hydroxyapatite (CaS/HA) biomaterials have been investigated for use in several orthopedic applications. However, the mechanical interactions between the composite of CaS/HA and bone at the microscale are still unknown. The aim of this study was to determine if and how augmentation with CaS/HA alters the fracture behavior of bone. Eleven cylinders of trabecular bone were drilled from human femoral heads and cleaned from bone marrow. Among them, five cylinders were injected with CaS/HA to generate composite specimens, while the others were kept intact. One extra specimen of pure CaS/HA was prepared. All specimens were compressed in situ using synchrotron X-ray tomography and imaged at ∼2% strain intervals. Structural properties were calculated from the images in unloaded state and mechanical properties were determined from the load-curves. CaS/HA alone displayed the highest peak force and stiffness and the lowest strain at fracture. All composite specimens had a higher peak force than the pure bone specimens and the composite specimens had higher toughness than the pure CaS/HA specimen. Furthermore, the fracture behavior was analyzed further to characterize the local deformations. The pure bone specimens presented damage in multiple trabeculae and the CaS/HA specimen displayed sharp transition in strains, with low strain in one load step and large cracks in the next. The composite specimens deformed uniformly, with the CaS/HA preventing tissue damage and the bone preventing cracks in the CaS/HA from propagating through the specimen. In conclusion, using tomography with in situ loading, it was possible to show how CaS/HA can help prevent bone tissue damage before global failure.

Identifiants

pubmed: 35385809
pii: S1751-6161(22)00119-9
doi: 10.1016/j.jmbbm.2022.105201
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Sulfates 0
Durapatite 91D9GV0Z28
Calcium Sulfate WAT0DDB505

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105201

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Joeri Kok (J)

Department of Biomedical Engineering, Lund University, Box 118, 221 00, Lund, Sweden. Electronic address: joeri.kok@bme.lth.se.

Elin Törnquist (E)

Department of Biomedical Engineering, Lund University, Box 118, 221 00, Lund, Sweden. Electronic address: elin.tornquist@bme.lth.se.

Deepak Bushan Raina (DB)

Department of Clinical Sciences, Orthopedics, Lund University, BMC C12, 221 84, Lund, Sweden. Electronic address: deepak.raina@med.lu.se.

Sophie Le Cann (S)

CNRS, Univ Paris Est Creteil, Univ Gustave Eiffel, UMR 8208, MSME, F-94010 Créteil, France. Electronic address: sophie.le-cann@u-pec.fr.

Vladimir Novak (V)

Swiss Light Source, Paul Scherrer Institute, Forschungsstrasse 111, 5232, Villigen, Switzerland. Electronic address: vladimir.novak@psi.ch.

Aurimas Širka (A)

Lithuania University of Health Science, A.Mickeviciaus ave.2, Kaunas, Lithuania. Electronic address: aurimas.sirka@lsmuni.lt.

Lars Lidgren (L)

Department of Clinical Sciences, Orthopedics, Lund University, BMC C12, 221 84, Lund, Sweden. Electronic address: lars.lidgren@med.lu.se.

Lorenzo Grassi (L)

Department of Biomedical Engineering, Lund University, Box 118, 221 00, Lund, Sweden. Electronic address: lorenzo.grassi@bme.lth.se.

Hanna Isaksson (H)

Department of Biomedical Engineering, Lund University, Box 118, 221 00, Lund, Sweden; Department of Clinical Sciences, Orthopedics, Lund University, BMC C12, 221 84, Lund, Sweden. Electronic address: hanna.isaksson@bme.lth.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH